About the webinar
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly NAFLD, is a complex metabolic disorder that can progress from fat accumulation to inflammation, fibrosis, and even liver cancer. Current treatments focus on lifestyle changes and medications to slow progression, but they cannot regenerate damaged liver tissue. Liver transplantation remains the last resort, limited by donor shortages and surgical risks.
In this webinar, Prof. Ashok Kumar from the Indian Institute of Technology Kanpur will discuss how DLP 3D bioprinting enables the creation of an “off-the-shelf” hepatic patch that delivers mesenchymal stem cell-derived exosomes for sustained, localized therapy and tissue regeneration.
Join us to learn about:
- Why MASLD requires new regenerative strategies
- How bioprinted scaffolds enhance exosome stability and controlled release
- Preclinical findings showing improved liver function and reduced fibrosis
